Serum Her-2/Neu a potential biomarker in breast cancer patients: correlation with the clinico-pathological parameters
IPMJ-Iraqi Postgraduate Medical Journal. 2015; 14 (4): 555-563
in English
| IMEMR
| ID: emr-177718
ABSTRACT
Background:
Breast cancer is the most common malignancy in women, and a major cause of mortality and morbidity despite the advances in diagnosis and treatment. There is evidence that changes in HER2 protein expressions are associated with breast cancer progression
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Peptide Fragments
/
Biomarkers, Tumor
/
Case-Control Studies
/
Receptor, ErbB-2
/
Antigens, Neoplasm
Limits:
Adult
/
Female
/
Humans
Language:
English
Journal:
Iraqi Postgrad. Med. J.
Year:
2015
Similar
MEDLINE
...
LILACS
LIS